Latest Financial Position News

Appen Limited reported a mixed Q2 FY25 with a 6% revenue decline year-over-year, driven by a strong 77% surge in its China business that achieved profitability, while US market challenges persist. The company targets $10 million in cost savings to fuel future growth.

Emerald Resources NL reported steady gold output at its Okvau Mine while unveiling significant resource expansions at its Dingo Range and Memot projects, alongside clearing its debt.

BCAL Diagnostics has reported strong early commercial uptake of its BREASTEST plus non-invasive breast cancer diagnostic test, alongside a new partnership with Cancer Care Associates to expand market reach.

Nexus Minerals has reported a significant new gold discovery at its Wallbrook Gold Project, highlighted by strong drilling results at the Payns Prospect, while progressing permitting for the Crusader-Templar deposit and maintaining a solid cash position.

Tlou Energy Limited’s latest quarterly cash flow report reveals a cautious financial position with A$2.74 million in available funding, supporting approximately 2.5 quarters of operations as exploration activities continue.

Tlou Energy progresses gas production testing at Lesedi wells while pushing forward the Kala Data Centre project, targeting operational start in Q3 2025.

S2 Resources advances exploration across multiple Australian projects with promising gold and base metal anomalies, while bolstering its balance sheet through a successful A$3.5 million capital raise.

Mamba Exploration Limited has decided to restart gold exploration at its Ashburton Project in Western Australia, backed by a strategic review and a cash position of $579,000. Historical data points to promising high-grade gold targets, setting the stage for a detailed exploration program.

Tolu Minerals reports significant progress at its Tolukuma Gold Mine, unveiling infrastructure upgrades and a $14.3 million exploration program aimed at boosting production and extending mine life.

Far East Gold has advanced drilling at its Bermol prospect in Indonesia, confirming key geological structures and preparing for expanded resource definition. The company also progresses copper-gold targets in Indonesia and maintains strong cash reserves to support ongoing exploration.

Noxopharm has initiated its HERACLES clinical trial for SOF-SKN, marking a key milestone for its Sofra platform, while deepening partnerships and actively seeking new funding to sustain development.

DroneShield Limited has reported a record-breaking second quarter with revenues surging 480% year-on-year, underpinned by a robust $176 million in committed sales and a $2.3 billion pipeline. The company is aggressively expanding manufacturing and investing in next-generation counter-drone technologies to meet soaring global demand.